Header Logo

Connection

Shabir Madhi to HIV Infections

Back to Details
This is a "connection" page, showing publications Shabir Madhi has written about HIV Infections.
Shabir Madhi
Connection Strength
14,170
HIV Infections
  1. Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV. AIDS. 2023 12 01; 37(15):2305-2310.
    View in: PubMed
    Score: 0,243
  2. Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial. Lancet Child Adolesc Health. 2023 05; 7(5):326-335.
    View in: PubMed
    Score: 0,234
  3. Human Metapneumovirus-Associated Hospitalization in HIV-1 Exposed Uninfected and HIV-1 Uninfected Children Less Than 5 Years in South Africa. J Pediatric Infect Dis Soc. 2023 Feb 09; 12(1):53-55.
    View in: PubMed
    Score: 0,233
  4. Antepartum SARS-CoV-2 infection and adverse birth outcomes in South African women. J Glob Health. 2022 Dec 03; 12:05050.
    View in: PubMed
    Score: 0,230
  5. T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa. AIDS. 2023 01 01; 37(1):105-112.
    View in: PubMed
    Score: 0,228
  6. Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial. Lancet HIV. 2022 05; 9(5):e309-e322.
    View in: PubMed
    Score: 0,220
  7. Tubercular Uveitis in Uveitis Cases in a High TB and HIV Setting: A Prospective Cohort Study. Transl Vis Sci Technol. 2022 01 03; 11(1):9.
    View in: PubMed
    Score: 0,216
  8. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV. 2021 09; 8(9):e568-e580.
    View in: PubMed
    Score: 0,210
  9. Hemagglutinin Stalk Antibody Responses Following Trivalent Inactivated Influenza Vaccine Immunization of Pregnant Women and Association With Protection From Influenza Virus Illness. Clin Infect Dis. 2020 08 14; 71(4):1072-1079.
    View in: PubMed
    Score: 0,196
  10. The unanticipated costs of COVID-19 to South Africa's quadruple disease burden. S Afr Med J. 2020 07 16; 110(8):698-699.
    View in: PubMed
    Score: 0,195
  11. Effect of HIV-exposure and timing of antiretroviral treatment initiation in children living with HIV on antibody persistence and memory responses to Haemophilus influenzae type b and pneumococcal polysaccharide-protein conjugate vaccines. Vaccine. 2020 03 10; 38(12):2651-2659.
    View in: PubMed
    Score: 0,189
  12. Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa. Vaccine. 2020 02 28; 38(10):2350-2360.
    View in: PubMed
    Score: 0,189
  13. Evaluation of the impact of HIV-1 infection and density of common nasopharyngeal bacterial colonizers in South African children immunized with 7-valent pneumococcal conjugate vaccine. Vaccine. 2020 02 11; 38(7):1762-1769.
    View in: PubMed
    Score: 0,187
  14. Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa. Clin Infect Dis. 2019 10 30; 69(10):1789-1796.
    View in: PubMed
    Score: 0,185
  15. Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children. J Infect Dis. 2019 09 26; 220(9):1529-1538.
    View in: PubMed
    Score: 0,184
  16. Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15-18 Months of Age Among Human Immunodeficiency Virus (HIV)-infected, HIV-exposed-uninfected, and HIV-unexposed Children. Clin Infect Dis. 2019 08 01; 69(4):687-696.
    View in: PubMed
    Score: 0,182
  17. Impaired Transplacental Transfer of Respiratory Syncytial Virus-neutralizing Antibodies in Human Immunodeficiency Virus-infected Versus -uninfected Pregnant Women. Clin Infect Dis. 2019 06 18; 69(1):151-154.
    View in: PubMed
    Score: 0,181
  18. Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants. PLoS One. 2019; 14(4):e0215079.
    View in: PubMed
    Score: 0,179
  19. Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women. PLoS One. 2018; 13(12):e0210124.
    View in: PubMed
    Score: 0,175
  20. Effect of HIV exposure and timing of antiretroviral therapy initiation on immune memory responses to diphtheria, tetanus, whole cell pertussis and hepatitis B vaccines. Expert Rev Vaccines. 2019 01; 18(1):95-104.
    View in: PubMed
    Score: 0,174
  21. Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study. Clin Infect Dis. 2018 05 17; 66(11):1658-1665.
    View in: PubMed
    Score: 0,168
  22. Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease. J Clin Virol. 2017 09; 94:50-56.
    View in: PubMed
    Score: 0,158
  23. Reduced Transplacental Transfer of Group B Streptococcus Surface Protein Antibodies in HIV-infected Mother-Newborn Dyads. J Infect Dis. 2017 02 01; 215(3):415-419.
    View in: PubMed
    Score: 0,153
  24. Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status. Medicine (Baltimore). 2017 Jan; 96(2):e5881.
    View in: PubMed
    Score: 0,152
  25. The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S165-S173.
    View in: PubMed
    Score: 0,151
  26. Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort Study. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S174-S180.
    View in: PubMed
    Score: 0,151
  27. Incidence of tuberculosis meningitis in a high HIV prevalence setting: time-series analysis from 2006 to 2011. Int J Tuberc Lung Dis. 2016 11; 20(11):1457-1462.
    View in: PubMed
    Score: 0,151
  28. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children. Vaccine. 2016 10 17; 34(44):5217-5224.
    View in: PubMed
    Score: 0,149
  29. Epidemiology of Acute Lower Respiratory Tract Infection in HIV-Exposed Uninfected Infants. Pediatrics. 2016 Apr; 137(4).
    View in: PubMed
    Score: 0,145
  30. The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience. Hum Vaccin Immunother. 2016; 12(2):314-25.
    View in: PubMed
    Score: 0,142
  31. Bacterial and Respiratory Viral Interactions in the Etiology of Acute Otitis Media in HIV-infected and HIV-uninfected South African Children. Pediatr Infect Dis J. 2015 Jul; 34(7):753-60.
    View in: PubMed
    Score: 0,137
  32. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis. Lancet Infect Dis. 2015 Sep; 15(9):1066-1076.
    View in: PubMed
    Score: 0,137
  33. Longitudinal study on Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonization in HIV-infected and -uninfected infants vaccinated with pneumococcal conjugate vaccine. Vaccine. 2015 May 28; 33(23):2662-9.
    View in: PubMed
    Score: 0,135
  34. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One. 2015; 10(4):e0123014.
    View in: PubMed
    Score: 0,135
  35. Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis. 2015 Apr; 21(4):638-45.
    View in: PubMed
    Score: 0,135
  36. Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa. J Infect Dis. 2015 Oct 01; 212(7):1082-92.
    View in: PubMed
    Score: 0,135
  37. Epidemiology of severe acute respiratory illness (SARI) among adults and children aged =5 years in a high HIV-prevalence setting, 2009-2012. PLoS One. 2015; 10(2):e0117716.
    View in: PubMed
    Score: 0,134
  38. HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women. J Infect Dis. 2015 Aug 01; 212(3):453-62.
    View in: PubMed
    Score: 0,133
  39. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 12 11; 371(24):2340.
    View in: PubMed
    Score: 0,132
  40. Polyomaviruses-associated respiratory infections in HIV-infected and HIV-uninfected children. J Clin Virol. 2014 Dec; 61(4):571-8.
    View in: PubMed
    Score: 0,131
  41. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 04; 371(10):918-31.
    View in: PubMed
    Score: 0,130
  42. The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life. BMC Med. 2014 Jul 17; 12:120.
    View in: PubMed
    Score: 0,128
  43. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS. 2014 Feb 20; 28(4):531-41.
    View in: PubMed
    Score: 0,125
  44. Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children. PLoS One. 2014; 9(2):e86448.
    View in: PubMed
    Score: 0,125
  45. Prospective cohort study comparing seasonal and H1N1(2009) pandemic influenza virus illnesses in HIV-infected children during 2009. Pediatr Infect Dis J. 2014 Feb; 33(2):174-6.
    View in: PubMed
    Score: 0,124
  46. Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization. Pediatr Infect Dis J. 2013 Nov; 32(11):1270-8.
    View in: PubMed
    Score: 0,122
  47. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2013 Nov; 19(11):1766-74.
    View in: PubMed
    Score: 0,122
  48. Dynamics of pneumococcal transmission in vaccine-naive children and their HIV-infected or HIV-uninfected mothers during the first 2 years of life. Am J Epidemiol. 2013 Dec 01; 178(11):1629-37.
    View in: PubMed
    Score: 0,122
  49. Impact of the antiretroviral treatment program on the burden of hospitalization for culture-confirmed tuberculosis in South African children: a time-series analysis. Pediatr Infect Dis J. 2013 Sep; 32(9):972-7.
    View in: PubMed
    Score: 0,121
  50. Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. AIDS. 2013 Jun 19; 27(10):1583-91.
    View in: PubMed
    Score: 0,119
  51. Acquisition of Streptococcus pneumoniae in pneumococcal conjugate vaccine-naïve South African children and their mothers. Pediatr Infect Dis J. 2013 May; 32(5):e192-205.
    View in: PubMed
    Score: 0,118
  52. Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants. Vaccine. 2013 Jan 21; 31(5):777-83.
    View in: PubMed
    Score: 0,115
  53. Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance. Paediatr Int Child Health. 2012 Aug; 32(3):140-6.
    View in: PubMed
    Score: 0,112
  54. Epidemiology of acute osteoarticular sepsis in a setting with a high prevalence of pediatric HIV infection. J Pediatr Orthop. 2012 Mar; 32(2):215-9.
    View in: PubMed
    Score: 0,109
  55. Antibiotic and systemic therapies for pneumonia in human immunodeficiency virus (HIV)-infected and HIV-exposed children. J Infect Dev Ctries. 2012 Feb 13; 6(2):109-19.
    View in: PubMed
    Score: 0,109
  56. Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother. 2012 Feb; 8(2):161-73.
    View in: PubMed
    Score: 0,108
  57. Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program. PLoS One. 2011; 6(11):e27929.
    View in: PubMed
    Score: 0,107
  58. Systematic review on the etiology and antibiotic treatment of pneumonia in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2011 Oct; 30(10):e192-202.
    View in: PubMed
    Score: 0,106
  59. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med. 2011 Jul 07; 365(1):21-31.
    View in: PubMed
    Score: 0,104
  60. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS. 2011 Feb 20; 25(4):453-62.
    View in: PubMed
    Score: 0,101
  61. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis. 2011 Jan 01; 52(1):128-37.
    View in: PubMed
    Score: 0,101
  62. Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis. 2010 Aug 15; 202(3):355-61.
    View in: PubMed
    Score: 0,098
  63. Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination. J Infect Dis. 2009 Apr 15; 199(8):1168-76.
    View in: PubMed
    Score: 0,089
  64. Seasonality, incidence, and repeat human metapneumovirus lower respiratory tract infections in an area with a high prevalence of human immunodeficiency virus type-1 infection. Pediatr Infect Dis J. 2007 Aug; 26(8):693-9.
    View in: PubMed
    Score: 0,079
  65. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine. 2007 Mar 22; 25(13):2451-7.
    View in: PubMed
    Score: 0,075
  66. Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children. Vaccine. 2005 Dec 01; 23(48-49):5517-25.
    View in: PubMed
    Score: 0,069
  67. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis. 2005 May 15; 40(10):1511-8.
    View in: PubMed
    Score: 0,068
  68. Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2425147.
    View in: PubMed
    Score: 0,066
  69. Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 - 2018. BMC Infect Dis. 2024 Oct 09; 24(1):1128.
    View in: PubMed
    Score: 0,065
  70. Immunogenicity and safety of SARS-CoV-2 recombinant spike protein vaccine in South African people living with and without HIV-1 infection: A phase 2 randomised trial. J Infect. 2024 Dec; 89(6):106285.
    View in: PubMed
    Score: 0,065
  71. T-cell responses to ancestral SARS-CoV-2 and Omicron variant among unvaccinated pregnant and postpartum women living with and without HIV in South Africa. Sci Rep. 2024 09 02; 14(1):20348.
    View in: PubMed
    Score: 0,065
  72. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004 Aug; 10(8):811-3.
    View in: PubMed
    Score: 0,064
  73. Characterization of bacterial and viral pathogens in the respiratory tract of children with HIV-associated chronic lung disease: a case-control study. BMC Infect Dis. 2024 Jun 26; 24(1):637.
    View in: PubMed
    Score: 0,064
  74. Factors affecting antenatal care attendance in Soweto, Johannesburg: The three-delay model. Afr J Prim Health Care Fam Med. 2024 Jun 14; 16(1):e1-e9.
    View in: PubMed
    Score: 0,064
  75. HIV and childhood tuberculosis: the way forward. Int J Tuberc Lung Dis. 2004 May; 8(5):675-82.
    View in: PubMed
    Score: 0,063
  76. Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management. PLoS One. 2024; 19(3):e0297159.
    View in: PubMed
    Score: 0,063
  77. Nanofluidic qPCR unable to detect and serotype Streptococcus pneumoniae in urine samples of hospitalized South African patients with community-acquired pneumonia. Sci Rep. 2023 12 04; 13(1):21332.
    View in: PubMed
    Score: 0,062
  78. Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin Infect Dis. 2003 Dec 15; 37(12):1705-10.
    View in: PubMed
    Score: 0,061
  79. Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination. Front Immunol. 2023; 14:1231276.
    View in: PubMed
    Score: 0,060
  80. Predictors of TB disease in HIV-exposed children from Southern Africa. Int J Tuberc Lung Dis. 2023 08 01; 27(8):619-625.
    View in: PubMed
    Score: 0,060
  81. Causes of Death Among Infants and Children in the Child Health and Mortality Prevention Surveillance (CHAMPS) Network. JAMA Netw Open. 2023 07 03; 6(7):e2322494.
    View in: PubMed
    Score: 0,060
  82. The attributable fraction of respiratory syncytial virus among patients of different ages with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016. Int J Infect Dis. 2023 Sep; 134:71-77.
    View in: PubMed
    Score: 0,059
  83. A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV. AIDS. 2023 07 01; 37(8):1227-1237.
    View in: PubMed
    Score: 0,059
  84. Evolution of the Gut Microbiome in HIV-Exposed Uninfected and Unexposed Infants during the First Year of Life. mBio. 2022 10 26; 13(5):e0122922.
    View in: PubMed
    Score: 0,056
  85. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Am J Obstet Gynecol. 2023 02; 228(2):161-177.
    View in: PubMed
    Score: 0,056
  86. Maternal-foetal transfer of severe acute respiratory syndrome coronavirus 2 antibodies among women with and those without HIV infection. AIDS. 2022 11 01; 36(13):1777-1782.
    View in: PubMed
    Score: 0,056
  87. Severe lower respiratory tract infections associated with human parainfluenza viruses 1-3 in children infected and noninfected with HIV type 1. Eur J Clin Microbiol Infect Dis. 2002 Jul; 21(7):499-505.
    View in: PubMed
    Score: 0,056
  88. Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial. Lancet Infect Dis. 2022 Oct; 22(10):1472-1483.
    View in: PubMed
    Score: 0,056
  89. Defining the potential impact of conjugate bacterial polysaccharide-protein vaccines in reducing the burden of pneumonia in human immunodeficiency virus type 1-infected and -uninfected children. Pediatr Infect Dis J. 2002 May; 21(5):393-9.
    View in: PubMed
    Score: 0,055
  90. Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV. Front Immunol. 2022; 13:873191.
    View in: PubMed
    Score: 0,055
  91. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr Infect Dis J. 2002 Apr; 21(4):291-7.
    View in: PubMed
    Score: 0,055
  92. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J. 2002 Apr; 21(4):315-21.
    View in: PubMed
    Score: 0,055
  93. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS. 2002 Jan 04; 16(1):105-12.
    View in: PubMed
    Score: 0,054
  94. Vaccination of the HIV-1 infected child. SADJ. 2001 Dec; 56(12):610-3.
    View in: PubMed
    Score: 0,054
  95. The Etiology of Pneumonia in HIV-uninfected South African Children: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study. Pediatr Infect Dis J. 2021 09 01; 40(9S):S59-S68.
    View in: PubMed
    Score: 0,053
  96. Mortality in children aged <5 years with severe acute respiratory illness in a high HIV-prevalence urban and rural areas of South Africa, 2009-2013. PLoS One. 2021; 16(8):e0255941.
    View in: PubMed
    Score: 0,052
  97. Epidemiology of severe COVID-19 from South Africa. Lancet HIV. 2021 09; 8(9):e524-e526.
    View in: PubMed
    Score: 0,052
  98. Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J. 2001 Feb; 20(2):164-70.
    View in: PubMed
    Score: 0,051
  99. Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa. Hum Vaccin Immunother. 2021 06 03; 17(6):1770-1778.
    View in: PubMed
    Score: 0,050
  100. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J. 2000 Dec; 19(12):1141-7.
    View in: PubMed
    Score: 0,050
  101. Burden of Tuberculosis in South African Children During Treatment for Underlying Malignancies: A Single-center Experience in Johannesburg. Pediatr Infect Dis J. 2020 12; 39(12):1111-1115.
    View in: PubMed
    Score: 0,050
  102. Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants. J Pediatric Infect Dis Soc. 2020 Jul 13; 9(3):349-356.
    View in: PubMed
    Score: 0,049
  103. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr. 2000 Jul; 137(1):78-84.
    View in: PubMed
    Score: 0,049
  104. COVID-19 lockdowns in low- and middle-income countries: Success against COVID-19 at the price of greater costs. S Afr Med J. 2020 06 19; 110(8):724-726.
    View in: PubMed
    Score: 0,048
  105. Characterization of human respiratory syncytial virus (RSV) isolated from HIV-exposed-uninfected and HIV-unexposed infants in South Africa during 2015-2017. Influenza Other Respir Viruses. 2020 07; 14(4):403-411.
    View in: PubMed
    Score: 0,047
  106. Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve human immunodeficiency virus-exposed infected and -uninfected South African children. Medicine (Baltimore). 2020 Feb; 99(9):e19353.
    View in: PubMed
    Score: 0,047
  107. Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial. Lancet HIV. 2020 02; 7(2):e91-e103.
    View in: PubMed
    Score: 0,047
  108. Rubella seroprevalence in pregnant women living with and without HIV in Soweto, South Africa. Int J Infect Dis. 2020 Feb; 91:255-260.
    View in: PubMed
    Score: 0,047
  109. The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus-associated Severe Respiratory Illness in South African Infants, 2011-2016. Clin Infect Dis. 2019 11 27; 69(12):2208-2211.
    View in: PubMed
    Score: 0,047
  110. Measles seroprevalence in pregnant women in Soweto, South Africa: a nested cohort study. Clin Microbiol Infect. 2020 Apr; 26(4):515.e1-515.e4.
    View in: PubMed
    Score: 0,046
  111. Maternal and neonatal vitamin D status at birth in black South Africans. S Afr Med J. 2019 Sep 30; 109(10):807-813.
    View in: PubMed
    Score: 0,046
  112. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting. Paediatr Int Child Health. 2020 02; 40(1):50-57.
    View in: PubMed
    Score: 0,045
  113. HIV-Exposed Uninfected Infants Have Increased Regulatory T Cells That Correlate With Decreased T Cell Function. Front Immunol. 2019; 10:595.
    View in: PubMed
    Score: 0,044
  114. The Role of Human Immunodeficiency Virus in Influenza- and Respiratory Syncytial Virus-associated Hospitalizations in South African Children, 2011-2016. Clin Infect Dis. 2019 02 15; 68(5):773-780.
    View in: PubMed
    Score: 0,044
  115. The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013-2015. Influenza Other Respir Viruses. 2018 05; 12(3):360-373.
    View in: PubMed
    Score: 0,041
  116. Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016. Emerg Infect Dis. 2017 07; 23(7):1124-1132.
    View in: PubMed
    Score: 0,039
  117. Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting. J Infect. 2017 10; 75(4):346-355.
    View in: PubMed
    Score: 0,039
  118. Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006-2014. Bull World Health Organ. 2017 Sep 01; 95(9):618-628.
    View in: PubMed
    Score: 0,039
  119. Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials. Clin Infect Dis. 2017 Jun 15; 64(12):1773-1779.
    View in: PubMed
    Score: 0,039
  120. Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children. Expert Rev Vaccines. 2017 May; 16(5):453-465.
    View in: PubMed
    Score: 0,039
  121. Development of a respiratory severity score for hospitalized adults in a high HIV-prevalence setting-South Africa, 2010-2011. BMC Pulm Med. 2017 02 02; 17(1):28.
    View in: PubMed
    Score: 0,038
  122. Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041. Int J Tuberc Lung Dis. 2017 01 01; 21(1):38-45.
    View in: PubMed
    Score: 0,038
  123. Multiplex Urinary Antigen Detection for 13 Streptococcus pneumoniae Serotypes Improves Diagnosis of Pneumococcal Pneumonia in South African HIV-Infected Adults. J Clin Microbiol. 2017 01; 55(1):302-312.
    View in: PubMed
    Score: 0,038
  124. Comparing the Yield of Nasopharyngeal Swabs, Nasal Aspirates, and Induced Sputum for Detection of Bordetella pertussis in Hospitalized Infants. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S181-S186.
    View in: PubMed
    Score: 0,038
  125. Risk Factors for Presumed Bacterial Pneumonia Among HIV-uninfected Children Hospitalized in Soweto, South Africa. Pediatr Infect Dis J. 2016 Nov; 35(11):1169-1174.
    View in: PubMed
    Score: 0,038
  126. Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study. Int J Tuberc Lung Dis. 2016 08; 20(8):1060-4.
    View in: PubMed
    Score: 0,037
  127. Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa. Clin Infect Dis. 2016 May 01; 62 Suppl 2:S188-95.
    View in: PubMed
    Score: 0,036
  128. Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants. PLoS One. 2016; 11(2):e0148649.
    View in: PubMed
    Score: 0,036
  129. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One. 2016; 11(2):e0149104.
    View in: PubMed
    Score: 0,036
  130. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis. 2016 May; 16(5):546-555.
    View in: PubMed
    Score: 0,036
  131. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination. AIDS. 2015 Jul 17; 29(11):1345-54.
    View in: PubMed
    Score: 0,034
  132. Human metapneumovirus-associated severe acute respiratory illness hospitalisation in HIV-infected and HIV-uninfected South African children and adults. J Clin Virol. 2015 Aug; 69:125-32.
    View in: PubMed
    Score: 0,034
  133. Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants. J Infect Dis. 2015 Dec 15; 212(12):1976-87.
    View in: PubMed
    Score: 0,034
  134. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children. Pediatr Pulmonol. 2016 Feb; 51(2):157-64.
    View in: PubMed
    Score: 0,034
  135. Deaths associated with respiratory syncytial and influenza viruses among persons =5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). Emerg Infect Dis. 2015 Apr; 21(4):600-8.
    View in: PubMed
    Score: 0,034
  136. Global, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and modelling study. Lancet Infect Dis. 2014 Dec; 14(12):1250-8.
    View in: PubMed
    Score: 0,033
  137. Genomic load from sputum samples and nasopharyngeal swabs for diagnosis of pneumococcal pneumonia in HIV-infected adults. J Clin Microbiol. 2014 Dec; 52(12):4224-9.
    View in: PubMed
    Score: 0,033
  138. Safety of licensed vaccines in HIV-infected persons: a systematic review protocol. Syst Rev. 2014 Sep 11; 3:101.
    View in: PubMed
    Score: 0,032
  139. Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia. BMJ Open. 2014 Aug 11; 4(8):e005953.
    View in: PubMed
    Score: 0,032
  140. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study. Clin Infect Dis. 2014 Sep 15; 59(6):808-18.
    View in: PubMed
    Score: 0,032
  141. Temporal association in hospitalizations for tuberculosis, invasive pneumococcal disease and influenza virus illness in South African children. PLoS One. 2014; 9(3):e91464.
    View in: PubMed
    Score: 0,031
  142. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ. 2014 Apr 01; 92(4):238-45.
    View in: PubMed
    Score: 0,031
  143. Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S217-26.
    View in: PubMed
    Score: 0,031
  144. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013 Nov 09; 382(9904):1555-63.
    View in: PubMed
    Score: 0,031
  145. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis. 2014 Jan 01; 209(1):56-65.
    View in: PubMed
    Score: 0,030
  146. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children. Vaccine. 2013 Sep 13; 31(40):4421-7.
    View in: PubMed
    Score: 0,030
  147. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Vaccine. 2012 Sep 07; 30 Suppl 3:C21-7.
    View in: PubMed
    Score: 0,028
  148. Maternal HIV infection and vertical transmission of pathogenic bacteria. Pediatrics. 2012 Sep; 130(3):e581-90.
    View in: PubMed
    Score: 0,028
  149. Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: potential benefits of rotavirus vaccine. Vaccine. 2012 Apr 27; 30 Suppl 1:A173-8.
    View in: PubMed
    Score: 0,028
  150. High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial. Int J Tuberc Lung Dis. 2012 Feb; 16(2):192-5.
    View in: PubMed
    Score: 0,027
  151. Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study. BMC Pediatr. 2011 Nov 21; 11:104.
    View in: PubMed
    Score: 0,027
  152. Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis. Int J Tuberc Lung Dis. 2011 Sep; 15(9):1194-200, i.
    View in: PubMed
    Score: 0,026
  153. Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization. Vaccine. 2011 Sep 16; 29(40):6994-7001.
    View in: PubMed
    Score: 0,026
  154. Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa. Pediatr Infect Dis J. 2011 Feb; 30(2):125-30.
    View in: PubMed
    Score: 0,025
  155. Maternal postpartum depression and infant social withdrawal among human immunodeficiency virus (HIV) positive mother-infant dyads. Psychol Health Med. 2010 May; 15(3):278-87.
    View in: PubMed
    Score: 0,024
  156. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010 Jan 28; 362(4):289-98.
    View in: PubMed
    Score: 0,024
  157. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines. Vaccine. 2010 Feb 17; 28(7):1677-83.
    View in: PubMed
    Score: 0,023
  158. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. J Infect Dis. 2009 Nov 01; 200 Suppl 1:S57-62.
    View in: PubMed
    Score: 0,023
  159. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008 Nov 20; 359(21):2233-44.
    View in: PubMed
    Score: 0,022
  160. Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa. Int J Antimicrob Agents. 2008 Nov; 32 Suppl 1:S66-70.
    View in: PubMed
    Score: 0,021
  161. HIV and pneumococcal disease. Curr Opin Infect Dis. 2007 Feb; 20(1):11-5.
    View in: PubMed
    Score: 0,019
  162. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children. J Clin Virol. 2006 Jul; 36(3):215-21.
    View in: PubMed
    Score: 0,018
  163. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol. 2006 Feb; 13(2):246-52.
    View in: PubMed
    Score: 0,018
  164. Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia. Pediatr Infect Dis J. 2006 Jan; 25(1):30-6.
    View in: PubMed
    Score: 0,018
  165. Use of procalcitonin and C-reactive protein to evaluate vaccine efficacy against pneumonia. PLoS Med. 2005 Feb; 2(2):e38.
    View in: PubMed
    Score: 0,017
  166. Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and -uninfected adults with pneumococcal bacteremia. J Infect Dis. 2004 Jun 01; 189(11):1996-2000.
    View in: PubMed
    Score: 0,016
  167. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003 Oct 02; 349(14):1341-8.
    View in: PubMed
    Score: 0,015
  168. Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet. 2002 Mar 23; 359(9311):992-3.
    View in: PubMed
    Score: 0,014
  169. Upper Respiratory Tract Co-detection of Human Endemic Coronaviruses and High-density Pneumococcus Associated With Increased Severity Among HIV-Uninfected Children Under 5 Years Old in the PERCH Study. Pediatr Infect Dis J. 2021 06 01; 40(6):503-512.
    View in: PubMed
    Score: 0,013
  170. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis. Pediatr Infect Dis J. 1999 Sep; 18(9):800-5.
    View in: PubMed
    Score: 0,011
  171. Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa. Vaccine. 2019 01 03; 37(1):25-33.
    View in: PubMed
    Score: 0,011
  172. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis. PLoS Med. 2018 07; 15(7):e1002591.
    View in: PubMed
    Score: 0,011
  173. Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions. Vaccine. 2017 08 03; 35(34):4321-4329.
    View in: PubMed
    Score: 0,010
  174. Standardization of Laboratory Methods for the PERCH Study. Clin Infect Dis. 2017 Jun 15; 64(suppl_3):S245-S252.
    View in: PubMed
    Score: 0,010
  175. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
    View in: PubMed
    Score: 0,010
  176. Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S187-S196.
    View in: PubMed
    Score: 0,009
  177. Challenges in reducing group B Streptococcus disease in African settings. Arch Dis Child. 2017 Jan; 102(1):72-77.
    View in: PubMed
    Score: 0,009
  178. Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study. Vaccine. 2016 11 04; 34(46):5649-5655.
    View in: PubMed
    Score: 0,009
  179. Streptococcus pneumoniae Serotypes and Mortality in Adults and Adolescents in South Africa: Analysis of National Surveillance Data, 2003 - 2008. PLoS One. 2015; 10(10):e0140185.
    View in: PubMed
    Score: 0,009
  180. Tuberculosis as a cause or comorbidity of childhood pneumonia in tuberculosis-endemic areas: a systematic review. Lancet Respir Med. 2015 Mar; 3(3):235-43.
    View in: PubMed
    Score: 0,008
  181. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J. 2015 Jan; 34(1):27-34.
    View in: PubMed
    Score: 0,008
  182. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014 Nov 13; 371(20):1889-99.
    View in: PubMed
    Score: 0,008
  183. Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009. Clin Infect Dis. 2014 May; 58(9):1241-9.
    View in: PubMed
    Score: 0,008
  184. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. Vaccine. 2013 Aug 28; 31(38):4200-8.
    View in: PubMed
    Score: 0,007
  185. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Ther Drug Monit. 2012 Aug; 34(4):446-51.
    View in: PubMed
    Score: 0,007
  186. Economic burden of acute lower respiratory tract infection in South African children. Paediatr Int Child Health. 2012 May; 32(2):65-73.
    View in: PubMed
    Score: 0,007
  187. Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa. PLoS One. 2012; 7(1):e27793.
    View in: PubMed
    Score: 0,007
  188. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis. 2012 Mar 01; 54(5):601-9.
    View in: PubMed
    Score: 0,007
  189. Pneumococcal vaccination in developing countries. Lancet. 2006 Jun 10; 367(9526):1880-2.
    View in: PubMed
    Score: 0,005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.